Biomerica (BMRA) announced that its Fortel Kidney Disease Test has been approved for sale by the United Arab Emirates Ministry of Health and Prevention. This key regulatory milestone enables Biomerica to offer its test across the UAE, a region facing a high burden of chronic kidney disease.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRA: